PlasmaN-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome (original) (raw)

Hartmann, Daniel, von Figura, Guido, Song, Zhangfa, Harden, Sharon, Scott, Lucy C, Evans, TR Jeffry ORCID logoORCID: https://orcid.org/0000-0002-4175-914X, Rudolph, Karl Lenhard, Bilsland, Alan E ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 and Keith, W Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580(2015) PlasmaN-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome.Future Oncology, 11(2), pp. 193-203. (doi: 10.2217/fon.14.166)

Publisher's URL: http://dx.doi.org/10.2217/fon.14.166

Abstract

Background:N-acetyl-glucosaminidase (NAG) is a potential marker of genotoxicity. We retrospectively analyzed plasma NAG and clinico-pathologic features in advanced gastrointestinal adenocarcinoma patients. Methods: Plasma from 118 patients and 51 healthy volunteers was analyzed for associations between NAG levels and age, disease presence, stage, treatment responses and survival. Results:Pretreatment NAG correlated with age but was independently increased in metastatic versus locally advanced disease, particularly in gastric/esophageal patients. NAG was also associated with reduced overall survival. In subgroup analysis, increased NAG activity between day 1 and 2 of chemotherapy cycle 1 correlated with treatment response.Conclusion:We demonstrated that NAG correlates with gastrointestinal cancer outcomes. Further studies are required to determine if plasma markers of genotoxicity can be useful for disease monitoring.

Item Type: Articles
Status: Published
Refereed: Yes
Glasgow Author(s) Enlighten ID: Scott, Dr Lucy and Bilsland, Dr Alan and Evans, Professor Jeff and Keith, Professor Nicol and Harden, Ms Sharon
Authors: Hartmann, D., von Figura, G., Song, Z., Harden, S., Scott, L. C., Evans, T. J., Rudolph, K. L., Bilsland, A. E., and Keith, W. N.
College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name: Future Oncology
Publisher: Future Medicine Ltd.
ISSN: 1479-6694
ISSN (Online): 1744-8301
Copyright Holders: Copyright © 2015 The Authors
First Published: First published in Future Oncology 11(2):193-203
Publisher Policy: Reproduced under a Creative Commons License
Related URLs: PubMed UK

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details

ID Code: 102061
Depositing User: Ms Mary Anne Meyering
Datestamp: 30 Jan 2015 11:47
Last Modified: 02 May 2025 04:42
Date of first online publication: 2015
Date Deposited: 15 December 2015
Data Availability Statement: No